EV/EBITDA
-0.77
-0.06-8.45%
65 min ago
Summary
- As of February 25, 2025, BCLI EV/EBITDA is -0.77, with a fall of -0.06 (-8.45%) during the most recent trading day.
- Over the past year, BCLI EV/EBITDA has increased by +0.23 (+23.00%).
- BCLI EV/EBITDA is now -92.50% below its all-time high of -0.40.
Performance
BCLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
BCLI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -8.4% | +8.7% | +9.3% |
| 1 m1 month | +27.4% | -27.3% | -28.7% |
| 3 m3 months | -11.6% | +12.1% | +13.1% |
| 6 m6 months | +49.7% | -59.3% | -67.8% |
| ytdytd | +20.6% | -20.7% | -21.9% |
| 1 y1 year | +23.0% | -52.6% | -68.8% |
| 5 y5 years | +92.6% | -95.8% | -98.8% |
BCLI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.4% | -1.06 | +27.4% | |
| 3 m | 3-month | -0.69 | -11.6% | -1.19 | +35.3% |
| 6 m | 6-month | -0.54 | -42.6% | -1.53 | +49.7% |
| 1 y | 1-year | -0.54 | -42.6% | -2.76 | +72.1% |
| 3 y | 3-year | -0.40 | -92.5% | -6.29 | +87.8% |
| 5 y | 5-year | -0.40 | -92.5% | -19.40 | +96.0% |
| alltime | all time | -0.40 | -92.5% | -27.87 | +97.2% |
Brainstorm Cell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.77(-20.6%) |
| 2024 | -0.97(+26.0%) |
| 2023 | -0.77(-70.3%) |
| 2022 | -2.59(-52.3%) |
| 2021 | -5.43(+32.8%) |
| 2020 | -4.09(-7.5%) |
| 2019 | -4.42(-15.2%) |
| 2018 | -5.21(-64.4%) |
| 2017 | -14.63(+56.1%) |
| Date | Value |
|---|---|
| 2016 | -9.37(+50.2%) |
| 2015 | -6.24(-32.4%) |
| 2014 | -9.23(+64.8%) |
| 2013 | -5.60(-37.8%) |
| 2012 | -9.01(+45.3%) |
| 2011 | -6.20(-21.1%) |
| 2010 | -7.86(-31.9%) |
| 2009 | -11.55(+761.9%) |
| 2008 | -1.34 |
FAQ
- What is Brainstorm Cell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Brainstorm Cell Therapeutics?
- What is BCLI EV/EBITDA year-to-date change?
- What is Brainstorm Cell Therapeutics EV/EBITDA year-on-year change?
What is Brainstorm Cell Therapeutics EV/EBITDA?
The current EV/EBITDA of BCLI is -0.77
What is the all time high EV/EBITDA for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high EV/EBITDA is -0.40
What is BCLI EV/EBITDA year-to-date change?
Brainstorm Cell Therapeutics EV/EBITDA has changed by +0.20 (+20.62%) since the beginning of the year
What is Brainstorm Cell Therapeutics EV/EBITDA year-on-year change?
Over the past year, BCLI EV/EBITDA has changed by +0.23 (+23.00%)